Inovio Pharma (INO) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.20 --0%
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Net loss attributable to Inovio Pharmaceuticals, Inc.: -20.76M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $12.54 million versus the consensus estimate of $5.16 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX stock drops as profit outlook falls short of analyst estimates
- Elauwit Connection, Inc. (ELWT) Misses Q2 EPS by 44c
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
